Fundraising Fox
GrayMatters Health
31 employees on LinkedIn · 4 known investors
Find your way into GrayMatters Health
Sign up to see every warm intro you have to GrayMatters Health
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GrayMatters Health team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GrayMatters Health develops Prism, an interventional psychiatry suite that uses fMRI-informed EEG digital biomarkers and self-neuromodulation to help patients regulate brain activity linked to conditions such as PTSD and depression. It is sold to psychiatry clinics to augment standard-of-care therapies.
Also known as GrayMatters Health
Investors · 4
J-Ventureslisted by J-VenturesSilicon Valley · $250K – $1M
How we know: J-Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Key figures
latest reportedHeadcountAug 202631
Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Frequently asked questions
- What does GrayMatters Health do?
- GrayMatters Health develops Prism, an interventional psychiatry suite that uses fMRI-informed EEG digital biomarkers and self-neuromodulation to help patients regulate brain activity linked to conditions such as PTSD and depression. It is sold to psychiatry clinics to augment standard-of-care therapies.
- Who are GrayMatters Health's investors?
- GrayMatters Health's investors include J-Impact, J-Ventures, Joyance Partners, Joy Ventures.